Liver support system

Patent metadata

Field	Value
Publication number	US-10265453-B2
Application number	US-201314646846-A
Country	US
Kind code	B2
Filing date	Nov 5, 2013
Priority date	Nov 26, 2012
Publication date	Apr 23, 2019
Grant date	Apr 23, 2019

Abstract

An artificial, extracorporeal system for liver replacement and/or assistance, comprises a liver dialysis device for conducting hemodialysis on a patient suffering from liver failure. The liver dialysis device comprises a first standard hollow fiber membrane dialyzer which does not allow passage of an essential amount of albumin over the membrane wall and which is perfused with the patient's blood, and a second hollow fiber membrane dialyzer which allows the passage of essential but defined amounts of albumin over the membrane wall and which receives the blood of the first standard hemodialyzer. The filtrate space is closed off from the lumen space of the hollow fibers and is populated by adsorbent material which may comprise one or more different adsorbents.

First claim

The invention claimed is:

1. A liver support device for conducting blood purification on a patient suffering from liver failure, comprising
(a) a first hollow fiber membrane dialyzer comprising i) a first hollow fiber membrane and ii) a first filtrate space,
wherein the first hollow fiber membrane dialyzer does not allow passage of an essential amount of albumin over a wall of the first hollow fiber membrane,
wherein the first hollow fiber membrane dialyzer is perfused with the patient's blood, and
wherein dialysate solution is passed in a continuous flow through the first filtrate space in a direction opposite to the blood flow within hollow fibers of the first hollow fiber membrane,
(b) a second hollow fiber membrane dialyzer comprising i) a second hollow fiber membrane and ii) a second filtrate space,
wherein the second hollow fiber membrane dialyzer allows passage of essential amounts of albumin over a wall of the second hollow fiber membrane, wherein the second filtrate space is closed off from a lumen space of the second hollow fiber membrane and is not perfused with any dialysis solution; and
(c) a particulate material comprising at least one adsorbent,
wherein the second filtrate space of the second hollow fiber membrane dialyzer is homogenously populated with the particulate material with a filling ratio of between 0.6 and 1.0, wherein the filling ratio is the volume in ml of the maximal amount of particulate material which can be accommodated in the filtrate space of a given hollow fiber membrane module (V PM ) and the utilizable volume in ml of the filtrate space of said module (V FS ):

Filling
⁢

⁢
ratio

=

V
PM

⁡

(
ml
)

V
FS

⁡

(
ml
)

wherein V PM represents the volume of the particulate material which can be accommodated in the filtrate space of the module, and V FS represents the utilizable filtrate space, and wherein V PM is calculated from

V
PM

⁡

(
ml
)

=

m
PM

⁡

(
g
)

ρ
⁡

(

g
⁢

/

⁢
ml

)

wherein m PM represents the amount of particulate material which can be accommodated in the filtrate space of the module and ρ represents the tapping density of the particulate material according to DIN ISO 3953.

2. A liver support device according to claim 1 wherein the second hollow fiber membrane of the second hollow fiber membrane dialyzer has a molecular weight cut-off in water, based on dextran sieving coefficients, of between 170 kilodaltons (kD) and 320 kD and a molecular weight retention onset in water, based on dextran sieving coefficients, of between 10 (kD) and 20 kD.

3. A liver support device according to claim 1 wherein the first hollow fiber membrane has a molecular weight cut-off in water, based on dextran sieving coefficients, of between 25 (kD) and 65 kD and a molecular weight retention onset in water, based on dextran sieving coefficients, of between 5 (kD) and 10 kD.

4. A liver support device according to claim 1 wherein the first hollow fiber membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer, wherein the at least one hydrophobic polymer is chosen from the group consisting of polyarylethersulfone (PAES), polypropylene (PP), polysulfone (PSU), polycarbonate (PC), polyacrylonitrile (PAN), polyamide (PA), polytetrafluorethylene (PTFE) or combinations thereof, and the at least one hydrophilic polymer is chosen from the group consisting of polyvinylpyrrolidone (PVP), polyethyleneglycol (PEG), polyvinylalcohol (PVA), and copolymer of polypropyleneoxide and polyethyleneoxide (PPO-PEO), or comprises a copolymer of acrylonitrile and sodium methallyl sulfonate.

5. A liver support device according to claim 1 wherein the first hollow fiber membrane comprises at least one hydrophobic polymer and at least one hydrophilic polymer, wherein the at least one hydrophobic polymer is chosen from the group consisting of polyarylethersulfone (PAES), polypropylene (PP), polysulfone (PSU), polycarbonate (PC), polyacrylonitrile (PAN), polyamide (PA), polytetrafluorethylene (PTFE) or combinations thereof, and the at least one hydrophilic polymer is chosen from the group consisting of polyvinylpyrrolidone (PVP), polyethyleneglycol (PEG), polyvinylalcohol (PVA), and copolymer of polypropyleneoxide and polyethyleneoxide (PPO-PEO).

6. A liver support device according to claim 1 wherein the second hollow fiber membrane allows passage of substances having a molecular weight of up to 45 kD with a sieving coefficient measured in whole blood of between 0.1 and 1.0, wherein the substances are selected from the group consisting of bilirubin, bile acids, aromatic amino acids, metabolites of aromatic amino acids, medium-chain fatty acids and cytokines.

7. A liver support device according to claim 1 wherein the second hollow fiber membrane has a molecular weight cut-off in water, based on dextran sieving coefficients, of between 170 (kD) and 320 kD and a molecular weight retention onset in water, based on dextran sieving coefficients, of between 15 (kD) and 20 kD.

8. A liver support device according to claim 1 wherein the second hollow fiber membrane dialyzer is located downstream from the first hollow fiber membrane dialyzer.

9. A liver support device according to claim 1 wherein the particulate material is one of hydrophobic and hydrophilic and is chosen from the group consisting of oxygen-containing adsorbents, carbon-based adsorbents and polymer-based adsorbents or combinations thereof.

10. A liver support device according to claim 9 wherein the hydrophobic particulate material is chosen from the group consisting of activated carbon, carbon nanotubes, hydrophobic silica, styrenic polymers, polydivinylbenzene polymers and styrene-divinylbenzene copolymers.

11. A liver support device according to claim 10 wherein the hydrophilic particulate material comprises one of:
a combination of at least one activated carbon, at least one copolymer of styrene and divinylbenzene without any functional groups and at least one copolymer of sty

Assignees

• Gambro Lundia Ab
• Gambro Lundia A B

Inventors

• Flieg Ralf
• Aldinger Stephan
• Storr Markus
• Krause Bernd

Classifications

• B01J20/28016

  Particle form · CPC title

• A61M2210/1071

  Liver; Hepar · CPC title

• A61M1/3475

  with filtrate treatment agent in the same enclosure as the membrane · CPC title

• B01D63/046

  in separate housings · CPC title

• B01D71/56

  Polyamides, e.g. polyester-amides · CPC title